1 |
Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A. 1995. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532
DOI
ScienceOn
|
2 |
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabionowitz D, Lallone RL, Burley SK, Friedman JM. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546
DOI
|
3 |
Sawdey S, Loskutoff DJ. 1991. Regulation of murine type 1 plasminogen activity inhibitor (PAI-1) gene expression in vivo. Tissue specificity and induction by lipolysaccharide, tumor necrosis factor and transforming growth factor b. J Clin Invest 8: 1346-1353
|
4 |
Lee H, Yang J, Kim Y, Kim Y. 2003. Nutritional regulation of plasminogen activator inhibitor-1, leptin and resistin gene expression in obese mouse. Nutr Sci 6: 73-77
|
5 |
Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol- cholroform extraction. Anal Biochem 162: 156-159
|
6 |
Morgange PE, Lijnen HR, Alessi MC, Kope F, Collen D, Juhan-Vague I. 2000. Influence of PAI-1 in adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 20: 1150-1154
DOI
ScienceOn
|
7 |
Halleux CM, Declerck PJ, Tran SL, Detry R, Brichard SM. 1999. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab 84: 4097-4105
DOI
|
8 |
Trayhurn P, Beattie JH. 2001. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60: 329-339
DOI
|
9 |
Zhang Y, Proence R, Maffel M, Barone M, Leopold L, Frledman JM. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432
DOI
ScienceOn
|
10 |
Hekman CM, Loskutoff DJ. 1985. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J Biol Chem 260: 11581-11587
|
11 |
Nordt TK, Sawa H, Fujii S, Sobel BE. 1995. Introduction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. Circulation 91: 764-770
DOI
ScienceOn
|
12 |
Kanu A, Fain JN, Bahouth SW, Cowan GS Jr. 2003. Regulation of leptin release by insulin, glucocorticoids, G(i)- coupled receptor agonists, and pertussis toxin in adipocytes and adipose tissue explants from obese humans in primary culture. Metabolism 52: 60-66
DOI
ScienceOn
|
13 |
Kim KH, Lee K, Moon YS, Sul HS. 2001. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276: 11252-11256
DOI
ScienceOn
|
14 |
Lee KN, Jeong IC, Lee SJ, Oh SH, Cho MY 2001. Regulation of leptin gene expression by insulin and growth hormone in mouse adipocytes. Exp Mol Med 33: 234-239
DOI
ScienceOn
|
15 |
Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. 1995. Effect of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543
DOI
|
16 |
Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA. 2001. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98: 502-506
DOI
ScienceOn
|
17 |
Juhan Vague I, Alessi MC. 1997. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 78: 656-660
|
18 |
Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, Lowell BB, Spiegelman BM. 1998. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 101: 1-9
DOI
ScienceOn
|
19 |
Yoshida T, Monkawa T, Hayashi M, Saruta T. 1997. Regulation of expression of leptin mRNA and secretion of leptin by thyroid hormone in 3T3-L1 adipocytes. Biochem Biophys Res Commun 232: 822-826
DOI
ScienceOn
|
20 |
Medina-Gomez G, Calvo RM, Obregon MJ. 2004. T3 and Triac inhibit leptin secretion and expression in brown and white rat adipocytes. Biochim Biophys Acta 1682: 38-47
DOI
ScienceOn
|
21 |
Shojima N, Sakoda H, Ogihara T, Fujishiro M, Katagiri H, Anai M, Onishi Y, Ono H, Inukai K, Abe M, Fukushima Y, Kikuchi M, Oka Y, Asano T. 2002. Hormonal regulation of resistion expression in 3T3-L1 and mouse adipose cells. Diabetes 51: 1737-1744
DOI
ScienceOn
|
22 |
Nogueiras R, Gualillo O, Caminos JE, Casanueva FF, Dieguez C. 2003. Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes Res 11: 408- 414
DOI
ScienceOn
|
23 |
Crandall DL, Busler DE, McHendry-Rinde B, Groeling TM, Kral JG. 2000. Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1. J Clin Endocrinol Metab 85: 2609-2614
DOI
ScienceOn
|
24 |
Kooistra T, Bosma PJ, Tons HA, van den Berg AP, Meyer P, Princen HM. 1989. Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Heamost 62: 723- 728
|
25 |
Samad F, Loskutoff DJ. 1996. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 2: 568-582
|
26 |
Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, Arner P. 1998. Adipose tissue secretion of plasminogen activator inhibitor-1 an non-obese and obese individuals. Diabetologia 41: 65-71
DOI
ScienceOn
|
27 |
Wahrenberg H, Wennlund A, Hoffstedt J. 2002. Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism. Eur J Endocrinol 146: 607-611
DOI
ScienceOn
|
28 |
Heaton JH, Nebes VL, O'bell LG, Morris SM Jr, Gelehrter TD. 1989. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activatorm inhibitor gene expression in primary cultures of rat hepatocytes. Mol Endocrinol 3: 185-192
DOI
ScienceOn
|